![]() ![]() Moreover, the risk of a fatal outcome is higher in patients with the severe form of the disease than the non-severe. However, 20% of patients are severe and critically ill cases who are at risk of progressing to acute respiratory distress syndrome (ARDS), acute respiratory failure and/or multiple organ dysfunction. The majority of COVID-19 patients experience mild to moderate respiratory illness and have no need for special treatment. As of Januthere are 86.920.070 cases and 1.878.057 deaths worldwide. Later on 11 March 2020, COVID-19 was declared a pandemic by the World Health Organization (WHO). On 7 January 2020, a novel strain of coronavirus, now referred to as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was isolated. So that with early diagnosis and intervention mortality in COVID-19 patients may be reduced.Īt the end of 2019, a group of similar pneumonia cases of unknown etiology in Wuhan City, China were reported. ![]() The nomogram developed in this study can be used by clinicians as a practical and effective tool in mortality risk estimation. The prediction ability of total points was excellent (Area Under Curve = 0.922). The elder age, certain comorbidities (cancer, heart failure, chronic renal failure), dyspnea, lower levels of oxygen saturation and hematocrit, higher levels of C-reactive protein, aspartate aminotransferase and ferritin were independent risk factors for mortality. Of the 709 patients treated for COVID-19, 75 (11%) died and 634 survived. A nomogram was developed with the possible predictors and total point were calculated. Multivariable Logistic Regression analysis was performed to assess the possible predictors of a fatal outcome. This retrospective study enrolled 709 patients who were over 18 years old and received inpatient treatment for COVID-19 disease. The aim of this study is to develop a functional nomogram that can be used by clinicians to estimate the risk of in-hospital mortality in patients hospitalized and treated for COVID-19 disease, and to compare the accuracy of model predictions with previous nomograms. Although there is no specific treatment available for COVID-19, early recognition and supportive treatment may reduce the mortality. One-fifth of COVID-19 patients are seriously and critically ill cases and have a worse prognosis than non-severe cases. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |